Neural regulation of immunity: Molecular mechanisms and clinical translation

Nature Neuroscience

Volumn 20, Issue 2, 2017, Pages 156-166

  Pavlov, Valentin A ^a   Tracey, Kevin J ^a  

^a Northwell Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; B LYMPHOCYTE; BRAIN FUNCTION; CATECHOLAMINERGIC SYSTEM; CELL FUNCTION; CELL TRANSPORT; CEREBROVASCULAR ACCIDENT; CONDITIONING; CROHN DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; INFLAMMATION; KIDNEY INJURY; METABOLIC SYNDROME X; NERVE; NERVE CELL; NERVE FUNCTION; NEURAL REFLEX; NEURAL REGULATION; NEUROMODULATION; NONHUMAN; OBESITY ASSOCIATED INFLAMMATION; PAVLOVIAN CONDITIONING; PROTECTION; REFLEX; REGULATORY MECHANISM; REVIEW; REWARD; RHEUMATOID ARTHRITIS; SEPSIS; SPINAL CORD INJURY; SPLENIC NERVE; T LYMPHOCYTE; TISSUE PROTECTION; VAGUS NERVE; VAGUS REFLEX; ANIMAL; IMMUNOLOGY; NERVE TRACT; NERVOUS SYSTEM FUNCTION; NEUROSCIENCE; PHYSIOLOGY; PROCEDURES;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNITY; INFLAMMATION; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NEURAL PATHWAYS; NEUROSCIENCES;

EID: 85009786054     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4477     Document Type: Review

References (147)

1. Borovikova, L.V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462 (2000).
2. Tracey, K.J. The inflammatory reflex. Nature 420, 853-859 (2002).
3. Chiu, I.M. et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature 501, 52-57 (2013).
4. Ueno, M., Ueno-Nakamura, Y., Niehaus, J., Popovich, P.G. & Yoshida, Y. Silencing spinal interneurons inhibits immune suppressive autonomic reflexes caused by spinal cord injury. Nat. Neurosci. 19, 784-787 (2016).
5. Mina-Osorio, P. et al. Neural signaling in the spleen controls B-cell responses to blood-borne antigen. Mol. Med. 18, 618-627 (2012).
6. Inoue, T. et al. Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury through α7nAChR+ splenocytes. J. Clin. Invest. 126, 1939-1952 (2016).
7. Wong, C.H., Jenne, C.N., Lee, W.Y., Léger, C. & Kubes, P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334, 101-105 (2011).
8. Rosas-Ballina, M. et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98-101 (2011).
9. Arima, Y. et al. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 148, 447-457 (2012).
10. Torres-Rosas, R. et al. Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat. Med. 20, 291-295 (2014).
11. Wang, L. et al. Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex. Nat. Med. 20, 484-492 (2014).
12. Ben-Shaanan, T.L. et al. Activation of the reward system boosts innate and adaptive immunity. Nat. Med. 22, 940-944 (2016).
13. Gabanyi, I. et al. Neuro-immune interactions drive tissue programming in intestinal macrophages. Cell 164, 378-391 (2016).
14. Pavlov, V.A. et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl. Acad. Sci. USA 103, 5219-5223 (2006).
15. Rosas-Ballina, M. et al. Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation. Brain Behav. Immun. 44, 19-27 (2015).
16. Ji, H. et al. Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis. Mucosal Immunol. 7, 335-347 (2014).
17. Miksa, M. et al. Pivotal role of the alpha(2A)-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis. PLoS One 4, e5504 (2009).
18. Levine, Y.A. et al. Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS One 9, e104530 (2014).
19. Brommer, B. et al. Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level. Brain 139, 692-707 (2016).
20. Prass, K. et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 198, 725-736 (2003).
21. Bonaz, B. et al. Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study. Neurogastroenterol. Motil. 28, 948-953 (2016).
22. Koopman, F.A. et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 113, 8284-8289 (2016).
23. Vivier, E. et al. Innate or adaptive immunity? The example of natural killer cells. Science 331, 44-49 (2011).
24. Hoebe, K., Janssen, E. & Beutler, B. The interface between innate and adaptive immunity. Nat. Immunol. 5, 971-974 (2004).
25. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
26. Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428-435 (2008).
27. Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995 (2004).
28. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
29. Davis, B.K., Wen, H. & Ting, J.P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707-735 (2011).
30. Nathan, C. & Ding, A. Nonresolving inflammation. Cell 140, 871-882 (2010).
31. Serhan, C.N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92-101 (2014).
32. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775-787 (2008).
33. Kelley, K.W. & McCusker, R.H. Getting nervous about immunity. Semin. Immunol. 26, 389-393 (2014).
34. Tracey, K.J. Understanding immunity requires more than immunology. Nat. Immunol. 11, 561-564 (2010).
35. Sun, J., Singh, V., Kajino-Sakamoto, R. & Aballay, A. Neuronal GPCR controls innate immunity by regulating noncanonical unfolded protein response genes. Science 332, 729-732 (2011).
36. Cao, X. & Aballay, A. Neural inhibition of dopaminergic signaling enhances immunity in a cell-non-autonomous manner. Curr. Biol. 26, 2329-2334 (2016).
37. Hosoi, T., Okuma, Y., Matsuda, T. & Nomura, Y. Novel pathway for LPS-induced afferent vagus nerve activation: possible role of nodose ganglion. Auton. Neurosci. 120, 104-107 (2005).
38. de Lartigue, G., Barbier de la Serre, C., Espero, E., Lee, J. & Raybould, H.E. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am. J. Physiol. Endocrinol. Metab. 301, E187-E195 (2011).
39. Ma, F., Zhang, L. & Westlund, K.N. Reactive oxygen species mediate TNFR1 increase after TRPV1 activation in mouse DRG neurons. Mol. Pain 5, 31 (2009).
40. Li, M. et al. Effects of complete Freund's adjuvant on immunohistochemical distribution of IL-1beta and IL-1R I in neurons and glia cells of dorsal root ganglion. Acta Pharmacol. Sin. 26, 192-198 (2005).
41. Kawashima, K., Fujii, T., Moriwaki, Y. & Misawa, H. Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function. Life Sci. 91, 1027-1032 (2012).
42. Cosentino, M. et al. HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines. Life Sci. 68, 283-295 (2000).
43. Pearce, J.M. Sir Charles Scott Sherrington (1857-1952) and the synapse. J. Neurol. Neurosurg. Psychiatry 75, 544 (2004).
44. Burke, R.E. Sir Charles Sherrington's the Integrative Action of the Nervous System: a centenary appreciation. Brain 130, 887-894 (2007).
45. Wood, J.D. The first Nobel Prize for integrated systems physiology: Ivan Petrovich Pavlov, 1904. Physiology (Bethesda) 19, 326-330 (2004).
46. Abboud, F.M. & Thames, M.D. Interaction of cardiovascular reflexes in circulatory control. in Comprehensive Physiology (ed. Pollock, D.M.) 675-753 (American Physiological Society, 2011).
47. Yaprak, M. The axon reflex. Neuroanatomy 7, 17-19 (2008).
48. Houghton, B.L., Meendering, J.R., Wong, B.J. & Minson, C.T. Nitric oxide and noradrenaline contribute to the temperature threshold of the axon reflex response to gradual local heating in human skin. J. Physiol. (Lond.) 572, 811-820 (2006).
49. Nieuwenhoff, M.D. et al. Reproducibility of axon reflex-related vasodilation assessed by dynamic thermal imaging in healthy subjects. Microvasc. Res. 106, 1-7 (2016).
50. Barnes, P.J. Asthma as an axon reflex. Lancet 1, 242-245 (1986).
51. Dampney, R.A. Central neural control of the cardiovascular system: current perspectives. Adv. Physiol. Educ. 40, 283-296 (2016).
52. Travagli, R.A., Hermann, G.E., Browning, K.N. & Rogers, R.C. Brainstem circuits regulating gastric function. Annu. Rev. Physiol. 68, 279-305 (2006).
53. Pavlov, V.A. & Tracey, K.J. The vagus nerve and the inflammatory reflex - linking immunity and metabolism. Nat. Rev. Endocrinol. 8, 743-754 (2012).
54. Mayer, E.A. Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 12, 453-466 (2011).
55. Pavlov, V.A., Wang, H., Czura, C.J., Friedman, S.G. & Tracey, K.J. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 9, 125-134 (2003).
56. Berthoud, H.R. & Neuhuber, W.L. Functional and chemical anatomy of the afferent vagal system. Auton. Neurosci. 85, 1-17 (2000).
57. Pavlov, P.I. Conditioned reflexes: an investigation of the physiological activity of the cerebral cortex. Ann. Neurosci. 17, 136-141 (2010).
58. Niijima, A. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J. Auton. Nerv. Syst. 61, 287-291 (1996).
59. Goehler, L.E. et al. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 85, 49-59 (2000).
60. Ordovas-Montanes, J. et al. The regulation of immunological processes by peripheral neurons in homeostasis and disease. Trends Immunol. 36, 578-604 (2015).
61. Goehler, L.E. et al. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J. Neurosci. 19, 2799-2806 (1999).
62. Tracey, K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117, 289-296 (2007).
63. Guarini, S. et al. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 107, 1189-1194 (2003).
64. Bernik, T.R. et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195, 781-788 (2002).
65. van Westerloo, D.J. et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130, 1822-1830 (2006).
66. de Jonge, W.J. et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6, 844-851 (2005).
67. Ghia, J.E., Blennerhassett, P., Kumar-Ondiveeran, H., Verdu, E.F. & Collins, S.M. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131, 1122-1130 (2006).
68. Ghia, J.E., Blennerhassett, P. & Collins, S.M. Vagus nerve integrity and experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G560-G567 (2007).
69. Pavlov, V.A. & Tracey, K.J. Neural circuitry and immunity. Immunol. Res. 63, 38-57 (2015).
70. Rosas-Ballina, M. et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl. Acad. Sci. USA 105, 11008-11013 (2008).
71. Wang, H. et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384-388 (2003).
72. Lu, B. et al. α7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release. Mol. Med. 20, 350-358 (2014).
73. Carnevale, D. et al. A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication. Nat. Commun. 7, 13035 (2016).
74. Mirakaj, V., Dalli, J., Granja, T., Rosenberger, P. & Serhan, C.N. Vagus nerve controls resolution and pro-resolving mediators of inflammation. J. Exp. Med. 211, 1037-1048 (2014).
75. Olofsson, P.S. et al. Single-pulse and unidirectional electrical activation of the cervical vagus nerve reduces tumor necrosis factor in endotoxemia. Bioelectronic Medicine 2, 37-42 (2015).
76. Song, J.G. et al. Electroacupuncture improves survival in rats with lethal endotoxemia via the autonomic nervous system. Anesthesiology 116, 406-414 (2012).
77. Chiu, I.M., von Hehn, C.A. & Woolf, C.J. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat. Neurosci. 15, 1063-1067 (2012).
78. Elenkov, I.J., Wilder, R.L., Chrousos, G.P. & Vizi, E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595-638 (2000).
79. Huston, J.M. et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203, 1623-1628 (2006).
80. Sabharwal, L. et al. The Gateway Reflex, which is mediated by the inflammation amplifier, directs pathogenic immune cells into the CNS. J. Biochem. 156, 299-304 (2014).
81. Nakai, A., Hayano, Y., Furuta, F., Noda, M. & Suzuki, K. Control of lymphocyte egress from lymph nodes through β2-adrenergic receptors. J. Exp. Med. 211, 2583-2598 (2014).
82. Meisel, C., Schwab, J.M., Prass, K., Meisel, A. & Dirnagl, U. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 6, 775-786 (2005).
83. Chamorro, A., Urra, X. & Planas, A.M. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38, 1097-1103 (2007).
84. Trakhtenberg, E.F. & Goldberg, J.L. Immunology. Neuroimmune communication. Science 334, 47-48 (2011).
85. Lucin, K.M., Sanders, V.M., Jones, T.B., Malarkey, W.B. & Popovich, P.G. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp. Neurol. 207, 75-84 (2007).
86. Inskip, J.A., Ramer, L.M., Ramer, M.S. & Krassioukov, A.V. Autonomic assessment of animals with spinal cord injury: tools, techniques and translation. Spinal Cord 47, 2-35 (2009).
87. Lucin, K.M., Sanders, V.M. & Popovich, P.G. Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury. J. Neurochem. 110, 1409-1421 (2009).
88. Medzhitov, R., Schneider, D.S. & Soares, M.P. Disease tolerance as a defense strategy. Science 335, 936-941 (2012).
89. Lawrence, A.J., Watkins, D. & Jarrott, B. Visualization of beta-adrenoceptor binding sites on human inferior vagal ganglia and their axonal transport along the rat vagus nerve. J. Hypertens. 13, 631-635 (1995).
90. Schreurs, J., Seelig, T. & Schulman, H. Beta 2-adrenergic receptors on peripheral nerves. J. Neurochem. 46, 294-296 (1986).
91. Rescorla, R.A. Pavlovian conditioning. It's not what you think it is. Am. Psychol. 43, 151-160 (1988).
92. MacQueen, G., Marshall, J., Perdue, M., Siegel, S. & Bienenstock, J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 243, 83-85 (1989).
93. Schedlowski, M. & Pacheco-López, G. The learned immune response: Pavlov and beyond. Brain Behav. Immun. 24, 176-185 (2010).
94. Goebel, M.U. et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 16, 1869-1873 (2002).
95. Longo, D.L. et al. Conditioned immune response to interferon-gamma in humans. Clin. Immunol. 90, 173-181 (1999).
96. Pacheco-López, G., Engler, H., Niemi, M.B. & Schedlowski, M. Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology. Brain Behav. Immun. 20, 430-446 (2006).
97. Benedetti, F., Mayberg, H.S., Wager, T.D., Stohler, C.S. & Zubieta, J.K. Neurobiological mechanisms of the placebo effect. J. Neurosci. 25, 10390-10402 (2005).
98. de la Fuente-Fernández, R. et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293, 1164-1166 (2001).
99. Owyang, C. & Heldsinger, A. Vagal control of satiety and hormonal regulation of appetite. J. Neurogastroenterol. Motil. 17, 338-348 (2011).
100. Morton, G.J., Cummings, D.E., Baskin, D.G., Barsh, G.S. & Schwartz, M.W. Central nervous system control of food intake and body weight. Nature 443, 289-295 (2006).
101. Luyer, M.D. et al. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J. Exp. Med. 202, 1023-1029 (2005).
102. Benarroch, E.E. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin. Proc. 68, 988-1001 (1993).
103. Shipley, M.T. Insular cortex projection to the nucleus of the solitary tract and brainstem visceromotor regions in the mouse. Brain Res. Bull. 8, 139-148 (1982).
104. Wrona, D. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J. Neuroimmunol. 172, 38-58 (2006).
105. Haas, H.S. & Schauenstein, K. Neuroimmunomodulation via limbic structures - the neuroanatomy of psychoimmunology. Prog. Neurobiol. 51, 195-222 (1997).
106. Picciotto, M.R., Higley, M.J. & Mineur, Y.S. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 76, 116-129 (2012).
107. Lee, S.T. et al. Cholinergic anti-inflammatory pathway in intracerebral hemorrhage. Brain Res. 1309, 164-171 (2010).
108. Pavlov, V.A. et al. Optogenetic stimulation of brain cholinergic networks suppresses inflammation. J. Immunology 196, 69.24 (2016).
109. Cabrera, L.Y., Evans, E.L. & Hamilton, R.H. Ethics of the electrified mind: defining issues and perspectives on the principled use of brain stimulation in medical research and clinical care. Brain Topogr. 27, 33-45 (2014).
110. Fregni, F. & Pascual-Leone, A. Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat. Clin. Pract. Neurol. 3, 383-393 (2007).
111. Pacheco-López, G. et al. Neural substrates for behaviorally conditioned immunosuppression in the rat. J. Neurosci. 25, 2330-2337 (2005).
112. Conner, J.M., Chiba, A.A. & Tuszynski, M.H. The basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injury. Neuron 46, 173-179 (2005).
113. Ballinger, E.C., Ananth, M., Talmage, D.A. & Role, L.W. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron 91, 1199-1218 (2016).
114. Morgan, K., Obici, S. & Rossetti, L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J. Biol. Chem. 279, 31139-31148 (2004).
115. Cheung, G.W., Kokorovic, A., Lam, C.K., Chari, M. & Lam, T.K. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab. 10, 99-109 (2009).
116. Olefsky, J.M. & Glass, C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219-246 (2010).
117. Gregor, M.F. & Hotamisligil, G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445 (2011).
118. Bastard, J.P. et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17, 4-12 (2006).
119. Carvalheira, J.B., Odegaard, J.I. & Chawla, A. A new role for the brain in metabolic control. Nat. Med. 20, 472-473 (2014).
120. Swinburn, B.A. et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 378, 804-814 (2011).
121. Cornier, M.A. et al. The metabolic syndrome. Endocr. Rev. 29, 777-822 (2008).
122. Gautron, L., Elmquist, J.K. & Williams, K.W. Neural control of energy balance: translating circuits to therapies. Cell 161, 133-145 (2015).
123. Satapathy, S.K. et al. Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol. Med. 17, 599-606 (2011).
124. Pardo, J.V. et al. Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int J Obes (Lond) 31, 1756-1759 (2007).
125. Parrish, W.R. et al. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol. Med. 14, 567-574 (2008).
126. Pavlov, V.A. et al. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit. Care Med. 35, 1139-1144 (2007).
127. Pavlov, V.A. et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun. 23, 41-45 (2009).
128. Tracey, K.J. Shock medicine. Sci. Am. 312, 28-35 (2015).
129. Steinman, L., Merrill, J.T., McInnes, I.B. & Peakman, M. Optimization of current and future therapy for autoimmune diseases. Nat. Med. 18, 59-65 (2012).
130. Eckel, R.H., Grundy, S.M. & Zimmet, P.Z. The metabolic syndrome. Lancet 365, 1415-1428 (2005).
131. Bouton, C.E. et al. Restoring cortical control of functional movement in a human with quadriplegia. Nature 533, 247-250 (2016).
132. Steinberg, B.E., Tracey, K.J. & Slutsky, A.S. Bacteria and the neural code. N. Engl. J. Med. 371, 2131-2133 (2014).
133. Katsnelson, A. Momentum grows to make 'personalized' medicine more 'precise'. Nat. Med. 19, 249 (2013).
134. Chan, A.C. & Behrens, T.W. Personalizing medicine for autoimmune and inflammatory diseases. Nat. Immunol. 14, 106-109 (2013).
135. Steinman, L. A century of Pavlovian experiments forming a circuit from the elucidation of neural reflexes to pharmaceuticals and electroceuticals to treat diseases. Brain Behav. Immun. 44, 17-18 (2015).
136. Chiu, I.M. et al. Transcriptional profiling at whole population and single cell levels reveals somatosensory neuron molecular diversity. eLife http://dx.doi.org/10.7554/eLife.04660 (2014).
137. Chang, R.B., Strochlic, D.E., Williams, E.K., Umans, B.D. & Liberles, S.D. Vagal sensory neuron subtypes that differentially control breathing. Cell 161, 622-633 (2015).
138. Williams, E.K. et al. Sensory neurons that detect stretch and nutrients in the digestive system. Cell 166, 209-221 (2016).
139. Akert, K. & Gernandt, B.E. Neurophysiological study of vestibular and limbic influences upon vagal outflow. Electroencephalogr. Clin. Neurophysiol. 14, 904-914 (1962).
140. Nagy, A. Cre recombinase: the universal reagent for genome tailoring. Genesis 26, 99-109 (2000).
141. Sanz, E. et al. Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc. Natl. Acad. Sci. USA 106, 13939-13944 (2009).
142. Urban, D.J. & Roth, B.L. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu. Rev. Pharmacol. Toxicol. 55, 399-417 (2015).
143. Deisseroth, K. Optogenetics: 10 years of microbial opsins in neuroscience. Nat. Neurosci. 18, 1213-1225 (2015).
144. Boyden, E.S. Optogenetics and the future of neuroscience. Nat. Neurosci. 18, 1200-1201 (2015).
145. Montgomery, K.L., Iyer, S.M., Christensen, A.J., Deisseroth, K. & Delp, S.L. Beyond the brain: optogenetic control in the spinal cord and peripheral nervous system. Sci. Transl. Med. 8, 337rv5 (2016).
146. Poulin, J.-F., Tasic, B., Hjerling-Leffler, J., Trimarchi, J.M. & Awatramani, R. Disentangling neural cell diversity using single-cell transcriptomics. Nat. Neurosci. 19, 1131-1141 (2016).
147. Tomer, R., Ye, L., Hsueh, B. & Deisseroth, K. Advanced CLARITY for rapid and high-resolution imaging of intact tissues. Nat. Protoc. 9, 1682-1697 (2014).